Blood markers for inflammation in heart attack
Part of Heart & circulation clinical trials.
This study is checking if a simple blood test (hs-CRP to albumin ratio) can help predict outcomes in people who have had a heart attack or unstable angina but are not getting an immediate balloon/stent procedure. It aims to use inflammation markers to guide better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with acute coronary syndrome (ACS) — a heart attack or unstable angina — and you are not eligible for a procedure called primary PCI (balloon or stent) right away.
- Your kidney function is good (eGFR of 60 or higher).
- You do not have cancer, chronic heart failure (NYHA class III or IV), chronic liver disease, nephrotic syndrome, or a recent stroke.
- You are not pregnant and have no recent infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether albumin levels in the blood are linked to how serious a heart attack or unstable angina is. If you've been admitted to the hospital with acute coronary syndrome, your albumin levels may be checked to see if they can help predict outcomes.
This study looks at whether certain blood markers (related to inflammation and heart damage) can help tell how well your heart is working after a heart attack. By joining, you could help doctors better predict heart function problems and improve care for future patients.
This study looks at blood “biomarkers” (signals in blood tests) in people who arrive with symptoms that could be a heart attack. It may help doctors spot and manage acute heart problems sooner and more accurately.
This study looks at whether two blood tests, one for a type of cholesterol and one for a ratio of certain cells, can predict how serious a heart attack is and how blocked the arteries are. The results might help doctors personalize treatment for people with acute coronary syndrome.
This study examines blood samples from people with different types of coronary artery disease to understand the condition better. It may help doctors learn how to treat heart problems in the future.
This study looks at two blood markers (mean platelet volume and systemic inflammatory response index) to see if they help predict outcomes in people admitted with a heart attack or unstable angina. If you've had chest pain from a heart condition and get to the hospital quickly, this could be relevant for you.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.